Revisão sistemática e metanálise dos desfechos CV e renais dos iSGLT2 - Euler Manenti - #Podcast 158

Feb 26, 2021

Autor: Euler Manenti

Ref: SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2018 Nov 9.